Howard Robin

Howard W.
Robin is President, Chief Executive Officer & Director at Nektar Therapeutics since 2007.
Formerly, Mr. Robin was President, Chief Executive Officer & Director at Sirna Therapeutics, Inc. from 2001 to 2006.
From 1984 to 2001, held roles at Berlex, Inc., including Director-Business Planning & Development from 1987 to 2001 and Vice President & General Manager from 1991 to 2001.
Also served as Director at Acologix, Inc., Biotechnology Innovation Organization, and The Bay Area Bioscience Association.
Worked as Senior Associate at Arthur Andersen LLP.
Served as Trustee at Fairleigh Dickinson University.
Education includes an undergraduate degree from Fairleigh Dickinson University, conferred in 1974.